Issued Patents All Time
Showing 26–49 of 49 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11512083 | Compounds and methods for the enhanced degradation of targeted proteins | Andrew P. Crew, Craig M. Crews, Xin Chen, Hanqing Dong, Caterina Ferraro +5 more | 2022-11-29 |
| 11427548 | Compounds and methods for the targeted degradation of androgen receptor | Andrew P. Crew, Hanqing Dong, Xin Chen, Yimin Qian, Kurt Zimmermann +2 more | 2022-08-30 |
| 11384063 | Modulators of estrogen receptor proteolysis and associated methods of use | Andrew P. Crew, Hanqing Dong, Yimin Qian | 2022-07-12 |
| 11352351 | Compounds and methods for the targeted degradation of androgen receptor | Meizhong Jin, Andrew P. Crew, Hanqing Dong, Xin Chen, Yimin Qian | 2022-06-07 |
| 11234986 | Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety | Troy David Patterson, Ze Tian | 2022-02-01 |
| 11191741 | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide | Andrew P. Crew, Lawrence B. Snyder, Yimin Qian, Michael Berlin | 2021-12-07 |
| 11173211 | Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides | Andrew P. Crew, Keith R. Hornberger, Saul Jaime-Figueroa, Hanqing Dong | 2021-11-16 |
| 11161841 | Modulators of proteolysis and associated methods of use | Andrew P. Crew, Keith R. Hornberger, Hanqing Dong | 2021-11-02 |
| 11104666 | Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders | Andrew P. Crew, Yimin Qian, Hanqing Dong, Keith R. Hornberger | 2021-08-31 |
| 10994015 | EGFR proteolysis targeting chimeric molecules and associated methods of use | Andrew P. Crew, Kurt Zimmermann, Craig M. Crews, Saul Jaime-Figueroa, George Burslem | 2021-05-04 |
| 10946017 | Tank-binding kinase-1 PROTACs and associated methods of use | Andrew P. Crew, Hanqing Dong, Yimin Qian | 2021-03-16 |
| 10899742 | Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders | Andrew P. Crew, Yimin Qian, Hanqing Dong | 2021-01-26 |
| 10865202 | Indole derivatives as estrogen receptor degraders | Andrew P. Crew, Yimin Qian, Hanqing Dong | 2020-12-15 |
| 10844021 | Compounds and methods for the targeted degradation of androgen receptor | Andrew P. Crew, Lawrence B. Snyder | 2020-11-24 |
| 10772962 | Compounds and methods for the targeted degradation of bromodomain-containing proteins | Yimin Qian, Hanqing Dong, Michael Berlin, Andrew P. Crew, Craig M. Crews | 2020-09-15 |
| 10730870 | Compounds and methods for the enhanced degradation of targeted proteins | Andrew P. Crew, Craig M. Crews, Xin Chen, Hanqing Dong, Caterina Ferraro +6 more | 2020-08-04 |
| 10723717 | Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides | Andrew P. Crew, Keith R. Hornberger, Hanqing Dong, Yimin Qian, Craig M. Crews +1 more | 2020-07-28 |
| 10702513 | Methods of treating pain and inducing analgesia | Edward Ziff | 2020-07-07 |
| 10647698 | Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders | Andrew P. Crew, Yimin Qian, Hanqing Dong | 2020-05-12 |
| 10604506 | Modulators of estrogen receptor proteolysis and associated methods of use | Andrew P. Crew, Keith R. Hornberger, Hanqing Dong, Yimin Qian, Craig M. Crews | 2020-03-31 |
| 10584101 | Compounds and methods for the targeted degradation of androgen receptor | Andrew P. Crew, Lawrence B. Snyder | 2020-03-10 |
| 10233249 | Antibodies and methods for treating estrogen receptor-associated diseases | Xueming Qian, Kun Meng, Feng-Jing Chen, Xiao Shang, Lu Li +1 more | 2019-03-19 |
| 10071164 | Estrogen-related receptor alpha based protac compounds and associated methods of use | Andrew P. Crew, Craig M. Crews, Hanqing Dong, Eunhwa Ko | 2018-09-11 |
| 7696197 | Use of a phenothiazine derivative for preventing and/or treating hearing loss | Bernadette Pignol, Jean-Luc Puel, Serge Auvin, Pierre-Entienne Chabrier de Lassauniere | 2010-04-13 |